B CELL MALIGNANCIES
Clinical trials for B CELL MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new B CELL MALIGNANCIES trials appear
Sign up with your email to follow new studies for B CELL MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo targets tough blood cancers
Disease control CompletedThis early-phase study tested a new drug called INCB040093, alone or with another drug (itacitinib), in 121 adults with B-cell blood cancers that had come back or stopped responding to prior treatments. The main goal was to find safe doses and check for side effects. Researchers …
Matched conditions: B CELL MALIGNANCIES
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC
-
Hidden danger: why some patients can't shake COVID-19
Knowledge-focused CompletedThis study tracked 204 patients with blood cancers or those on certain immune-suppressing treatments to see how often COVID-19 infection persists for 21 days or more. Researchers also looked for factors that make a long infection more likely. The goal was to better understand who…
Matched conditions: B CELL MALIGNANCIES
Sponsor: Maddalena Giannella • Aim: Knowledge-focused
Last updated Jun 12, 2026 12:08 UTC